Skip to main content
BENF
NASDAQ Finance

Beneficient Acquires $8.75M Asset via Highly Dilutive Convertible Preferred Stock, Seeks Shareholder Approval

Analysis by Wiseek.ai
Sentiment info
Negative
Importance info
8
Price
$4.16
Mkt Cap
$52.591M
52W Low
$1.75
52W High
$12.48
Market data snapshot near publication time

summarizeSummary

Beneficient acquired an $8.75 million asset in exchange for Series B-10 Resettable Convertible Preferred Stock, which could lead to over 50% dilution and requires shareholder approval for full conversion.


check_boxKey Events

  • Acquisition of $8.75M Asset

    Beneficient acquired an $8.75 million limited partner interest in an investment fund, increasing collateral for its loan portfolio and adding $9.77 million to tangible book value.

  • Issuance of Dilutive Preferred Stock

    The company issued 875,214 shares of Series B-10 Resettable Convertible Preferred Stock, convertible into up to 7,047,947 Class A Common Shares.

  • Unfavorable Conversion Terms

    The preferred stock has an initial conversion price of $3.5479 (below current market) and a reset mechanism with a floor of $1.2418, indicating significant potential dilution for common shareholders.

  • Shareholder Vote for Full Conversion

    Shareholder approval is required for conversions exceeding Nasdaq's Exchange Cap, highlighting the material dilutive impact on common stock.


auto_awesomeAnalysis

This filing details a significant primary capital transaction where Beneficient acquired an $8.75 million limited partner interest in an investment fund. While the transaction adds a substantial asset (approximately 16.6% of the current market cap) and is expected to increase tangible book value by $9.77 million, it comes with highly dilutive terms for existing common shareholders. The company issued 875,214 shares of Series B-10 Resettable Convertible Preferred Stock, convertible at an initial price of $3.5479, which is below the current market price, and can reset down to a floor of $1.2418. The maximum potential conversion of 7,047,947 shares represents over 50% potential dilution based on current outstanding shares. The company is also seeking shareholder approval for conversions exceeding Nasdaq's Exchange Cap, highlighting the material impact on common stock. For a company facing a "going concern" warning, securing capital and assets is critical for survival, but the terms reflect the company's distressed position and pose a significant overhang for common stock.

At the time of this filing, BENF was trading at $4.16 on NASDAQ in the Finance sector, with a market capitalization of approximately $52.6M. The 52-week trading range was $1.75 to $12.48. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed BENF - Latest Insights

BENF
Apr 20, 2026, 7:49 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
9
BENF
Apr 10, 2026, 7:44 AM EDT
Filing Type: DEFA14A
Importance Score:
8
BENF
Apr 10, 2026, 7:40 AM EDT
Filing Type: 8-K
Importance Score:
8
BENF
Apr 06, 2026, 6:11 PM EDT
Filing Type: 424B3
Importance Score:
9
BENF
Mar 13, 2026, 4:30 PM EDT
Filing Type: DEF 14A
Importance Score:
9
BENF
Mar 12, 2026, 7:46 AM EDT
Filing Type: 424B3
Importance Score:
8
BENF
Mar 12, 2026, 7:45 AM EDT
Filing Type: 8-K
Importance Score:
8
BENF
Feb 17, 2026, 5:21 PM EST
Filing Type: 10-Q
Importance Score:
10
BENF
Feb 17, 2026, 5:08 PM EST
Filing Type: 8-K
Importance Score:
8
BENF
Jan 21, 2026, 7:17 AM EST
Filing Type: 424B3
Importance Score:
8